A share price of Fresenius Medical Care AG ADR [FMS] is currently trading at $23.77, up 0.55%. An important factor to consider is whether the stock is rising or falling in short-term value. The FMS shares have gain 4.76% over the last week, with a monthly amount glided 1.62%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Fresenius Medical Care AG ADR [NYSE: FMS] stock has seen the most recent analyst activity on October 15, 2025, when BofA Securities downgraded its rating to a Underperform. Previously, UBS downgraded its rating to Sell on September 02, 2025. On December 02, 2024, upgrade upgraded it’s rating to Neutral. Berenberg started tracking the stock assigning a Buy rating and suggested a price target of $25.60 on November 06, 2024. Morgan Stanley downgraded its rating to an Underweight. HSBC Securities upgraded its rating to Hold for this stock on November 24, 2023. In a note dated November 17, 2023, Societe Generale upgraded a Buy rating on this stock.
Fresenius Medical Care AG ADR experienced fluctuations in its stock price throughout the past year between $22.05 and $30.46. Currently, Wall Street analysts expect the stock to reach $17.85 within the next 12 months. Fresenius Medical Care AG ADR [NYSE: FMS] shares were valued at $23.77 at the most recent close of the market. An investor can expect a potential drop of -24.91% based on the average FMS price forecast.
Analyzing the FMS fundamentals
Trailing Twelve Months sales for Fresenius Medical Care AG ADR [NYSE:FMS] were 21.71B which represents 9.16% growth. Gross Profit Margin for this corporation currently stands at 0.25% with Operating Profit Margin at 0.08%, Pretax Profit Margin comes in at 0.06%, and Net Profit Margin reading is 0.03%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.05 and Total Capital is 0.06. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.83.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 23.63 points at the first support level, and at 23.49 for the second support level. However, for the 1st resistance point, the stock is sitting at 23.90, and for the 2nd resistance point, it is at 24.02.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Fresenius Medical Care AG ADR [NYSE:FMS] is 1.36. On the other hand, the Quick Ratio is 1.00, and the Cash Ratio is 0.3. Considering the valuation of this stock, the price to sales ratio is 0.63, the price to book ratio is 0.91 and price to earnings (TTM) ratio is 17.25.
